Greg Critchfield, former president of Myriad Genetics Laboratories, has been appointed as lead director of the board of Metamark Genetics. He has served on Metamark's board since September and is also the CEO of Sera Prognostics.
Prior to Myriad, he served as chief medical and science officer for Corning Clinical Laboratories, which later became Quest Diagnostics.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
